Raloxifene and the prevention of breast cancer.

about

Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.

P2860

Q37312970-D0373F6C-E54B-4D2C-8D56-2C185EADED08

P2860

Raloxifene and the prevention of breast cancer.

Item

http://www.wikidata.org/entity/Q36632266

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Raloxifene and the prevention of breast cancer.

@ast

Raloxifene and the prevention of breast cancer.

@en

type

Item

label

Raloxifene and the prevention of breast cancer.

@ast

Raloxifene and the prevention of breast cancer.

@en

prefLabel

Raloxifene and the prevention of breast cancer.

@ast

Raloxifene and the prevention of breast cancer.

@en

P1476

Raloxifene and the prevention of breast cancer.

@en

P2093

Therese B Bevers

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.

Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Design and methods of the Raloxifene Use for The Heart (RUTH) study.

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.

Phase II evaluation of Ly156758 in metastatic breast cancer.

P304

2301-2307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.7.16.2301

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17059385

http://www.w3.org/2001/XMLSchema#string

Raloxifene and the prevention of breast cancer.

about

P2860

P2860

Raloxifene and the prevention of breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698